Interestingly, FAM134B acts as an oncogene in hepatocellular carcinoma (HCC) and esophageal squamous cell carcinoma (ESCC), while it acts as a tumor suppressor in colorectal cancer (CRC) and breast cancer [34]. The gene discussed is RETREG1; the disease is breast cancer.